{
  "retracted": true,
  "timestamp": 1402358400000,
  "updates": [
    {
      "timestamp": 1589289967158,
      "identifier": {
        "doi": "10.1038/bjc.2014.314"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/bjc.2014.72"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Retraction Note: Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies"
}
